Research ArticleClinical Investigations
Validation of Several SUV-Based Parameters Derived from 18F-FDG PET for Prediction of Survival After SIRT of Hepatic Metastases from Colorectal Cancer
Wolfgang Peter Fendler, Donfack Beauclair Philippe Tiega, Harun Ilhan, Philipp M. Paprottka, Volker Heinemann, Tobias F. Jakobs, Peter Bartenstein, Marcus Hacker and Alexander Robert Haug
Journal of Nuclear Medicine August 2013, 54 (8) 1202-1208; DOI: https://doi.org/10.2967/jnumed.112.116426
Wolfgang Peter Fendler
1Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany
Donfack Beauclair Philippe Tiega
1Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany
Harun Ilhan
1Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany
Philipp M. Paprottka
2Department of Clinical Radiology, Ludwig-Maximilians-University of Munich, Munich, Germany
Volker Heinemann
3Department of Internal Medicine III, Ludwig-Maximilians-University of Munich, Munich, Germany
4Comprehensive Cancer Center, Ludwig-Maximilians-University of Munich, Munich, Germany; and
Tobias F. Jakobs
5Department of Diagnostic and Interventional Radiology, Krankenhaus Barmherzige Brüder München, Munich, Germany
Peter Bartenstein
1Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany
4Comprehensive Cancer Center, Ludwig-Maximilians-University of Munich, Munich, Germany; and
Marcus Hacker
1Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany
Alexander Robert Haug
1Department of Nuclear Medicine, Ludwig-Maximilians-University of Munich, Munich, Germany
4Comprehensive Cancer Center, Ludwig-Maximilians-University of Munich, Munich, Germany; and
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 54, Issue 8
August 1, 2013
Validation of Several SUV-Based Parameters Derived from 18F-FDG PET for Prediction of Survival After SIRT of Hepatic Metastases from Colorectal Cancer
Wolfgang Peter Fendler, Donfack Beauclair Philippe Tiega, Harun Ilhan, Philipp M. Paprottka, Volker Heinemann, Tobias F. Jakobs, Peter Bartenstein, Marcus Hacker, Alexander Robert Haug
Journal of Nuclear Medicine Aug 2013, 54 (8) 1202-1208; DOI: 10.2967/jnumed.112.116426
Validation of Several SUV-Based Parameters Derived from 18F-FDG PET for Prediction of Survival After SIRT of Hepatic Metastases from Colorectal Cancer
Wolfgang Peter Fendler, Donfack Beauclair Philippe Tiega, Harun Ilhan, Philipp M. Paprottka, Volker Heinemann, Tobias F. Jakobs, Peter Bartenstein, Marcus Hacker, Alexander Robert Haug
Journal of Nuclear Medicine Aug 2013, 54 (8) 1202-1208; DOI: 10.2967/jnumed.112.116426
Jump to section
Related Articles
Cited By...
- Additional Local Therapy for Liver Metastases in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Systemic PSMA-Targeted Therapy
- 18F-FDG PET/CT in Local Ablative Therapies: A Systematic Review
- SIRFLOX: Progression-Free Survival in the Liver As a Surrogate End Point for Survival?
- Safety, Efficacy, and Prognostic Factors After Radioembolization of Hepatic Metastases from Breast Cancer: A Large Single-Center Experience in 81 Patients
- Use of PERCIST for Prediction of Progression-Free and Overall Survival After Radioembolization for Liver Metastases from Pancreatic Cancer
- Prognostic Value of Metabolic Tumor Volume and Total Lesion Glycolysis on Preoperative 18F-FDG PET/CT in Patients with Pancreatic Cancer